Posted: December 2017 How do you envision immunotherapy interdigitating in the adjuvant and neoadjuvant setting in resectable nonsmall cell lung cancer (NSCLC)? PACIFIC, which demonstrated a marked progression-free survival (PFS) […] Read more
By Suresh Senan, MRCP, FRCR, PhD Posted: December 2017 Improved delivery of radiotherapy has contributed to the recent changes in guidelines for patients with lung cancer. The clinical impact of […] Read more
By Cynthia L. Kryder, MS Posted: December 2017 The IASLC WCLC 2017 Presidential Symposium in Yokohama, Japan, recognized the authors of 3 exceptional lung cancer research abstracts. Patient-reported Outcomes from […] Read more
By Cynthia L. Kryder, MSPosted: December 2017 Despite genomic advances in the treatment of advanced lung cancer over the past decade, few breakthroughs have emerged in the adjuvant treatment of […] Read more